Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-015411
Filing Date
2017-12-15
Accepted
2017-12-15 12:27:43
Documents
2
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3674
2 ex24stoner.txt EX-24 5036
  Complete submission text file 0001179110-17-015411.txt   10089
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Issuer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address
Stoner Elizabeth (Reporting) CIK: 0001415739 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50797 | Film No.: 171258334